Biotechnology workshop of the Silesian Park of Technology Kardio-Med Silesia with Celon Pharma – the market leader of innovative pharmaceutical companies in Poland!

7 December 2022 / 08:37

A biotechnology workshop of representatives of the Silesian Park of Medical Technology Kardio-Med Silesia with the company Celon Pharma S.A. was held on 06.12.2022. Celon Parma S.A. is an innovative pharmaceutical company that conducts advanced scientific research and produces modern drugs. The workshop on the part of the Silesian Park of Medical Technology Kardio-Med.

Silesia was attended by:

  • Adam Konka – Chairman of the Silesian Park of Medical Technology Kardio-Med Silesia
  • Ewa Malada – Manager of Lab. Test and Implementation Lab of New Technologies and Medical Devices
  • Marzena Dyhdalewicz – GLP/GMP Specialist
  • Dominika Korner – Research Group Leader of the project “Personalized liposome-based small inhibitory RNA therapy for acute myeloid leukemia (OBS/AML)”

We would like to thank for organizing this workshop at the headquarters of Celon Pharma S.A. Mr. President Dr. Maciej Wieczorek. We hope that this workshop will result in the establishment of a lasting research collaboration between Celon Pharma S.A. and the Silesian Park of Medical Technology Kardio-Med Silesia.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    I consent to the processing of my personal data by Śląski Park Technologii Medycznych Kardio-Med Silesia Sp. z o.o., 10C M. Curie-Skłodowskiej St., 41-800 Zabrze, KRS:0000396540, NIP:6482761515, Regon:242742607, as Data Controler in order to receive a response. I can withdraw my consent by submitting a statement to: The Data Controler has notified me that this consent does not affect the legality of the processing carried out on the basis of consent before its withdrawal.

    The information clause on the details of the processing is available here.

    Supporting partners: